It should be noted that in a study with 15 stage-I-IIA NSCLC and 30 normal controls, elevated EBC IL-17A was observed in NSCLC patients compared to normal controls, albeit at lower concentrations (<3 pg/mL) [48], which is lower than the detection limits of the kit used in this study. This evidence concerns the gene IL17A and non-small cell lung carcinoma.